PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $545,000 | -93.6% | 55,350 | -93.0% | 0.01% | -93.6% |
Q4 2016 | $8,575,000 | -47.9% | 785,975 | -33.1% | 0.11% | -44.4% |
Q3 2016 | $16,458,000 | -16.3% | 1,174,730 | -58.1% | 0.20% | +63.6% |
Q2 2016 | $19,666,000 | +105.2% | 2,801,286 | +88.3% | 0.12% | -4.7% |
Q1 2016 | $9,583,000 | -69.6% | 1,487,998 | +53.1% | 0.13% | -70.3% |
Q4 2015 | $31,486,000 | +56.0% | 971,793 | +28.6% | 0.43% | +58.1% |
Q3 2015 | $20,178,000 | -27.4% | 755,728 | +30.9% | 0.27% | -17.4% |
Q2 2015 | $27,789,000 | -20.1% | 577,378 | +1.0% | 0.33% | -20.0% |
Q1 2015 | $34,771,000 | +11.3% | 571,423 | -5.3% | 0.41% | +21.7% |
Q4 2014 | $31,233,000 | +24.2% | 603,308 | +5.6% | 0.34% | +20.4% |
Q3 2014 | $25,143,000 | +253.9% | 571,300 | +110.2% | 0.28% | +304.3% |
Q2 2014 | $7,105,000 | +264.9% | 271,813 | +264.8% | 0.07% | +165.4% |
Q1 2014 | $1,947,000 | +76.4% | 74,500 | +14.5% | 0.03% | +73.3% |
Q4 2013 | $1,104,000 | +5.3% | 65,050 | +33.2% | 0.02% | +15.4% |
Q3 2013 | $1,048,000 | – | 48,850 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |